Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,787.00+5.07%ETH$2,431.65+7.47%GOLD$4,134.30+1.51%OIL$87.17-1.08%
Smart Investors Daily
SID Premium
ConvaTec Group Plc logo

OTC · CNVVY

ConvaTec Group Plc

Healthcare · Medical - Instruments & Supplies

$13.88

Up+$0.70 (+5.28%)

Updated Nov 5, 2026, 9:48 AM

SID Score

5.8/10

Composite research score

Smart Money

46/100

Neutral

Market cap
6.28B
P/E ratio
28.99
Dividend yield
1.87%
52-week range
— – —
Volume
572
Avg. volume
24.37K

Price performance · CNVVY

CNVVY price history

1M range · 0 trading sessions · Daily adjusted prices

CNVVY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest CNVVY news

The latest Smart Investors Daily articles mentioning CNVVY.

Stock researchCompany · Overview

CNVVY research

Overview

Company profile and research snapshot.

Company profile

CONVATEC GRP PLC UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$16.93
Implied upside
—
Analysts
21
CNVVY recent ratings
DateFirmRatingTarget
Jun 8, 2026JefferiesBuy—
May 22, 2026JP Morgan CazenoveOverweight—
May 18, 2026UBSBuy—
May 18, 2026CitigroupNeutral—
May 15, 2026JefferiesBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 22, 2026

Convatec Recognized With Two Prestigious Vizient® Supplier Excellence Awards

BOSTON, October 22, 2026--Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, announced it has been recognized by Vizient®, the largest provider-driven healthcare performance improvement company in the United States, with two distinguished supplier awards, including 2026 Non-Acute Supplier of the Year and 2026 Medical and Surgical Excellence Award.

Yahoo · Oct 16, 2026

Is Convatec Group (LSE:CTEC) Trading Below Fair Value On Cash Flow?

Convatec Group shares have logged a 29.0% gain over the past 5 years, which puts more focus on whether the current price lines up with the cash the business can generate. With the stock recently closing at £2.37, the question for you is how that market tag compares with what a detailed cash flow view suggests. A 29.0% return over 5 years means long term holders have seen steady value creation on paper. The key issue now is whether those gains are supported by the company’s cash...

Yahoo · Oct 6, 2026

Convatec Survey Challenges Assumptions About Leakage in Ostomy Care

LONDON, October 06, 2026--Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today released Rethinking leakage in ostomy care, new international research highlighting a significant gap in how peristomal skin health is understood and managed in ostomy care. The findings indicate that skin health plays a critical role in preventing leakage, and supporting confidence in daily life, yet remains widely under-recognised in routi

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By